Experience
Elan Pharmaceuticals, Inc.
Ivax Pharmaceuticals, Inc.
Represented Elan in Hatch-Waxman patent infringement action against Ivax seeking FDA approval to market generic copies of Permax®, ultimately concluded after product sold to another party.
Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc., 2:01-cv-01974, D.N.J., Judge Martini
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.
Dow Pharmaceutical Sciences, Inc.; Valeant
Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.
Dow Pharmaceutical Sciences, Inc.
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
Dow Pharmaceutical Sciences, Inc. v. Actavis, Inc.
Dow Pharmaceutical Sciences, Inc.
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.